1887

Abstract

The equine sarcoid, a locally aggressive, fibroblastic skin tumour, is the most common dermatological neoplasm reported in horses; there is no consistently effective therapy. It is widely accepted that bovine papillomavirus (BPV) types 1 and 2 are associated with the pathogenesis of sarcoid disease. Most sarcoids appear to contain detectable viral DNA and RNA and are also known to express the BPV types 1 and 2 major transforming protein, E5, but appear not to produce infectious virions. While the mode of transmission of infection has not been elucidated, viral gene expression, in particular of E5, may contribute to virus persistence and disease pathogenesis by downregulating MHC class I expression. Here, the pathology and epidemiology of the sarcoid and its association with BPV is reviewed; the transforming functions of the BPV oncoproteins and their possible role in sarcoid pathogenesis are discussed; and the practical implications of BPV infection for diagnostic and therapeutic purposes are considered.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18947-0
2003-05-01
2020-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/5/vir841055.html?itemId=/content/journal/jgv/10.1099/vir.0.18947-0&mimeType=html&fmt=ahah

References

  1. Amtmann, E., Muller, H. & Sauer, G. ( 1980; ). Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA. J Virol 35, 962–964.
    [Google Scholar]
  2. Angelos, J. A., Oppenheim, Y., Rebhun, W., Mohammed, H. & Antczak, D. F. ( 1988; ). Evaluation of breed as a risk factor for sarcoid and uveitis in horses. Anim Genet 19, 417–425.
    [Google Scholar]
  3. Angelos, J. A., Marti, E., Lazary, S. & Carmichael, L. E. ( 1991; ). Characterization of BPV-like DNA in equine sarcoids. Arch Virol 119, 95–109.[CrossRef]
    [Google Scholar]
  4. Ashrafi, G. H., Tsirimonaki, E., Marchetti, B., O'Brien, P. M., Sibbet, G. J., Andrew, L. & Campo, M. S. ( 2002; ). Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21, 248–259.[CrossRef]
    [Google Scholar]
  5. Bloch, N., Breen, M. & Spradbrow, P. B. ( 1994; ). Genomic sequences of bovine papillomaviruses in formalin-fixed sarcoids from Australian horses revealed by polymerase chain reaction. Vet Microbiol 41, 163–172.[CrossRef]
    [Google Scholar]
  6. Boiron, M., Levy, J. P., Thomas, M., Freidman, J. C. & Bernard, J. C. ( 1964; ). Some properties of bovine papillomavirus. Nature 201, 423.[CrossRef]
    [Google Scholar]
  7. Breitburd, F., Ramoz, N., Salmon, J. & Orth, G. ( 1996; ). HLA control in the progression of human papillomavirus infections. Semin Cancer Biol 7, 359–371.[CrossRef]
    [Google Scholar]
  8. Brostrom, H. ( 1989; ). Surface antigens on equine sarcoid cells and normal dermal fibroblasts as assessed by xenogenic antisera. Res Vet Sci 46, 172–179.
    [Google Scholar]
  9. Brostrom, H. ( 1995; ). Equine sarcoids. A clinical and epidemiological study in relation to equine leucocyte antigens (ELA). Acta Vet Scand 36, 223–236.
    [Google Scholar]
  10. Brostrom, H., Bredberg-Raden, U., England, J., Obel, N. & Perlmann, P. ( 1979; ). Cell-mediated immunity in horses with sarcoid tumours against sarcoid cells in vitro. Am J Vet Res 40, 1701–1706.
    [Google Scholar]
  11. Brostrom, H., Fahlbrink, E., Dubath, M.-L. & Lazary, S. ( 1988; ). Association between equine leucocyte antigens (ELA) and equine sarcoid tumours in the population of Swedish halfbreds and some of their families. Vet Immunol Immunopathol 19, 215–223.[CrossRef]
    [Google Scholar]
  12. Bucher, K., Szalai, G., Marti, E., Griot-Wenk, M. E., Lazary, S. & Pauli, U. ( 1996; ). Tumour suppressor gene p53 in the horse: identification, cloning, sequencing and a possible role in the pathogenesis of equine sarcoid. Res Vet Sci 61, 114–119.[CrossRef]
    [Google Scholar]
  13. Campo, M. S. ( 1997a; ). Bovine papillomavirus and cancer. Vet J 154, 175–188.[CrossRef]
    [Google Scholar]
  14. Campo, M. S. ( 1997b; ). Vaccination against papillomavirus in cattle. Clin Dermatol 15, 275–283.[CrossRef]
    [Google Scholar]
  15. Campo, M. S., Grindlay, G. J., O'Neil, B. W., Chandrachud, L. M., McGarvie, G. M. & Jarrett, W. F. H. ( 1993; ). Prophylactic and therapeutic vaccination against a mucosal papillomavirus. J Gen Virol 74, 945–953.[CrossRef]
    [Google Scholar]
  16. Carr, E. A., Theon, A. P., Madewell, B. R., Hitchcock, M. E., Schlegel, R. & Schiller, J. T. ( 2001a; ). Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses. Am J Vet Res 62, 1212–1217.[CrossRef]
    [Google Scholar]
  17. Carr, E. A., Theon, A. P., Madewell, B. R., Griffey, S. M. & Hitchcock, M. E. ( 2001b; ). Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States. Am J Vet Res 62, 741–744.[CrossRef]
    [Google Scholar]
  18. Cheevers, W. P., Roberson, S. M., Brassfield, A. L., Davis, W. C. & Crawford, T. B. ( 1982; ). Isolation of a retrovirus from cultured equine sarcoid tumour cells. Am J Vet Res 43, 804–806.
    [Google Scholar]
  19. Cheevers, W. P., Fatemi-Nainie, S. & Anderson, L. W. ( 1986; ). Spontaneous expression of an endogenous retrovirus by the equine sarcoid-derived MC-1 cell line. Am J Vet Res 47, 50–52.
    [Google Scholar]
  20. Chen, J. J., Reid, C. E., Band, V. & Androphy, E. J. ( 1995; ). Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269, 529–531.[CrossRef]
    [Google Scholar]
  21. DiMaio, D. & Mattoon, D. ( 2001; ). Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 20, 7866–7873.[CrossRef]
    [Google Scholar]
  22. England, J. J., Watson, R. E., Jr & Larson, K. A. ( 1973; ). Virus-like particles in an equine sarcoid cell line. Am J Vet Res 34, 1601–1603.
    [Google Scholar]
  23. Faccini, A. M., Cairney, M., Ashrafi, G. H., Finbow, M. E., Campo, M. S. & Pitts, J. D. ( 1996; ). The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. J Virol 70, 9041–9045.
    [Google Scholar]
  24. Fatemi-Nainie, S., Anderson, L. W. & Cheevers, W. P. ( 1982; ). Identification of a transforming retrovirus from cultured equine dermal fibrosarcoma. Virology 120, 490–494.[CrossRef]
    [Google Scholar]
  25. Fatemi-Nainie, S., Anderson, L. W. & Cheevers, W. P. ( 1984; ). Culture characteristics and tumorigenicity of the equine sarcoid-derived MC-1 cell line. Am J Vet Res 45, 1105–1108.
    [Google Scholar]
  26. Gerber, H., Dubath, M.-L. & Lazary, L. ( 1988; ). Association between predisposition to equine sarcoid and MHC in multiple-case families. In Equine Infectious Diseases, Proceedings of the Fifth International Conference, pp 272–277. Edited by D. G. Powel. Kentucky: University Press.
  27. Giannoudis, A. & Herrington, C. S. ( 2001; ). Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193, 295–302.[CrossRef]
    [Google Scholar]
  28. Goldschmidt, M. H. & Hendrick, M. J. ( 2002; ). Equine sarcoid. In Tumours in Domestic Animals, 4th edition, pp 88–89. Edited by D. J. Meuten. Iowa: Iowa State University Press.
  29. Goodrich, L., Gerber, H., Marti, E. & Antczack, D. F. ( 1998; ). Equine sarcoids. Vet Clin N Am Equine Prac 14, 607–623.
    [Google Scholar]
  30. Han, R., Breitburd, F., Marche, P. N. & Orth, G. ( 1992; ). Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes. Nature 356, 66–68.[CrossRef]
    [Google Scholar]
  31. IARC. ( 1995; ). Monographs on the evaluation of carcinogenic risk to humans. In Human Papillomaviruses. World Health Organization International Agency for Research on Cancer.
  32. Jackson, C. ( 1936; ). The incidence and pathology of tumours of domesticated animals in South Africa. Onderstepoort J Vet Sci Anim Ind 6, 378–385.
    [Google Scholar]
  33. James, V. S. ( 1968; ). A family tendency to equine sarcoid. SW Vet 21, 235–236.
    [Google Scholar]
  34. Jarrett, W. F. H., Smith, K. T., O'Neil, B. W., Gaukrodger, J. M., Chandrachud, L. M., Grindlay, G. J., McGarvie, G. M. & Campo, M. S. ( 1991; ). Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology 184, 33–42.[CrossRef]
    [Google Scholar]
  35. Kemp-Symonds, J. G. ( 2000; ). The detection and sequencing of bovine papillomavirus type 1 and 2 DNA from Musca autumnalis (Diptera: Muscidae) face flies infesting sarcoid-affected horses. MSc thesis, Royal Veterinary College, London, UK.
  36. Knottenbelt, D. C. & Walker, J. A. ( 1994; ). Treatment of the equine sarcoid. Equine Vet Educ 6, 72–75.[CrossRef]
    [Google Scholar]
  37. Lancaster, W. D. ( 1981; ). Apparent lack of integration of bovine papillomavirus DNA in virus-induced equine and bovine tumor cells and virus-transformed mouse cells. Virology 108, 251–255.[CrossRef]
    [Google Scholar]
  38. Lancaster, W. D., Theilen, G. H. & Olson, C. ( 1979; ). Hybridization of bovine papilloma virus type 1 and type 2 DNA to DNA from virus-induced hamster tumors and naturally occurring equine tumors. Intervirology 11, 227–233.[CrossRef]
    [Google Scholar]
  39. Lazary, S., Gerber, H., Glatt, P. A. & Straub, R. ( 1985; ). Equine leucocyte antigens in sarcoid-affected horses. Equine Vet J 17, 283–286.[CrossRef]
    [Google Scholar]
  40. Lory, S., von Tscharner, C., Marti, E., Bestetti, G., Grimm, S. & Waldvogel, A. ( 1993; ). In situ hybridisation of equine sarcoids with bovine papilloma virus. Vet Rec 132, 132–133.[CrossRef]
    [Google Scholar]
  41. Marchetti, B., Ashrafi, G. H., Tsirimonaki, E., O'Brien, P. M. & Campo, M. S. ( 2002; ). The papillomavirus oncoprotein E5 retains the major histocompatibility class I in the Golgi apparatus and prevents its transport to the cell surface. Oncogene 21, 7808–7816.[CrossRef]
    [Google Scholar]
  42. Martens, A., De Moor, A., Demeulemeester, J. & Peelman, L. ( 2001a; ). Polymerase chain reaction analysis of the surgical margins of equine sarcoids for bovine papilloma virus DNA. Vet Surg 30, 460–467.[CrossRef]
    [Google Scholar]
  43. Martens, A., De Moor, A. & Ducatelle, R. ( 2001b; ). PCR detection of bovine papilloma virus DNA in superficial swabs and scrapings from equine sarcoids. Vet J 161, 280–286.[CrossRef]
    [Google Scholar]
  44. Marti, E., Lazary, S., Antczak, D. F. & Gerber, H. ( 1993; ). Report of the first international workshop on equine sarcoid. Equine Vet J 25, 397–407.[CrossRef]
    [Google Scholar]
  45. Meredith, D., Elser, A. H., Wolf, B., Soma, L. R., Donawick, W. J. & Lazary, S. ( 1986; ). Equine leukocyte antigens: relationships with sarcoid tumors and laminitis in two pure breeds. Immunogenetics 23, 221–225.[CrossRef]
    [Google Scholar]
  46. Mohammed, H. O., Rebhun, W. C. & Antczack, D. F. ( 1992; ). Factors associated with the risk of developing sarcoid tumours in horses. Equine Vet J 24, 165–168.[CrossRef]
    [Google Scholar]
  47. Nasir, L. & Reid, S. W. J. ( 1999; ). Bovine papillomaviral gene expression in equine sarcoid tumours. Virus Res 61, 171–175.[CrossRef]
    [Google Scholar]
  48. Nasir, L., McFarlane, S. T., Torrontegui, B. O. & Reid, S. W. J. ( 1997; ). Screening for bovine papillomavirus in peripheral blood cells of donkeys with and without sarcoids. Res Vet Sci 63, 289–290.[CrossRef]
    [Google Scholar]
  49. Nasir, L., McFarlane, S. T. & Reid. ( 1999; ). Mutational status of the tumour suppressor gene (p53) in donkey sarcoid tumours. Vet J 157, 99–101.[CrossRef]
    [Google Scholar]
  50. Ned, R., Allen, S. & Vande Pol, S. ( 1997; ). Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6. J Virol 71, 4866–4870.
    [Google Scholar]
  51. O'Brien, P. M. & Campo, M. S. ( 2002; ). Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res 88, 103–117.[CrossRef]
    [Google Scholar]
  52. Olson, C., Jr & Cook, R. H. ( 1951; ). Cutaneous sarcoma-like lesions of the horse caused by the agent of bovine papilloma. Proc Soc Exp Biol Med 77, 281–284.[CrossRef]
    [Google Scholar]
  53. Otten, N., Von Tscharner, C., Lazary, S., Antczak, D. F. & Gerber, H. ( 1993; ). DNA of bovine papillomavirus type 1 and 2 in equine sarcoids: PCR detection and direct sequencing. Arch Virol 132, 121–131.[CrossRef]
    [Google Scholar]
  54. Pascoe, R. R. & Summers, P. M. ( 1981; ). Clinical survey of tumours and tumour-like lesions in horses in south east Queensland. Equine Vet J 13, 235–239.[CrossRef]
    [Google Scholar]
  55. Ragland, W. L. & Spencer, G. R. ( 1969; ). Attempts to relate bovine papilloma virus to the cause of equine sarcoid: equidae inoculated intradermally with bovine papilloma virus. Am J Vet Res 30, 743–752.
    [Google Scholar]
  56. Ragland, W. L., Keown, G. H. & Gorham. ( 1966; ). An epizootic of equine sarcoid. Nature 210, 1399.[CrossRef]
    [Google Scholar]
  57. Ragland, W. H., Keown, G. H. & Spencer, G. R. ( 1970; ). Equine sarcoid. Equine Vet J 2, 2–11.[CrossRef]
    [Google Scholar]
  58. Rapp, L., Liu, Y., Hong, Y., Androphy, E. J. & Chen, J. J. ( 1999; ). The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor α-induced apoptosis. Oncogene 18, 607–615.[CrossRef]
    [Google Scholar]
  59. Reid, S. W. J. ( 1992; ). The equine sarcoid: molecular and epidemiological studies in Equus asinus. PhD thesis, University of Glasgow, Glasgow, UK.
  60. Reid, S. W. J. & Mohammed, H. O. ( 1997; ). Longitudinal and cross-sectional studies to evaluate the risk of sarcoid associated with castration. Can J Vet Res 61, 89–93.
    [Google Scholar]
  61. Reid, S. W. J., Smith, K. T. & Jarrett, W. H. F. ( 1994; ). Detection, cloning and characterisation of papillomaviral DNA present in sarcoid tumours of Equus asinus. Vet Rec 135, 430–432.[CrossRef]
    [Google Scholar]
  62. Robl, M. G. & Olson, C. ( 1968; ). Oncogenic action of bovine papilloma virus in hamsters. Cancer Res 28, 1596–1604.
    [Google Scholar]
  63. Schapiro, F., Sparkowski, J., Adduci, A., Suprynowicz, F., Schlegel, R. & Grinstein, S. ( 2000; ). Golgi alkalinization by the papillomavirus E5 oncoprotein. J Cell Biol 148, 305–315.[CrossRef]
    [Google Scholar]
  64. Scheffner, M., Werness, B. A., Huibregtse J. M., Levine, A. J. & Howley, P. M. ( 1990; ). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129–1136.[CrossRef]
    [Google Scholar]
  65. Shope, R. E. ( 1933; ). Infectious papillomatosis of rabbits; with a note on the histopathology. J Exp Med 58, 607–624.[CrossRef]
    [Google Scholar]
  66. Siegsmund, M., Wayss, K. & Amtmann, E. ( 1991; ). Activation of latent papillomavirus genomes by chronic mechanical irritation. J Gen Virol 72, 2787–2789.[CrossRef]
    [Google Scholar]
  67. Sousa, R., Dostatni, N. & Yaniv, M. ( 1990; ). Control of papillomavirus gene expression. Biochim Biophys Acta 1032, 19–37.
    [Google Scholar]
  68. Straight, S. W., Herman, B. & McCance, D. J. ( 1995; ). The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 69, 3185–3192.
    [Google Scholar]
  69. Sundberg, J. P., Burnstein, T., Page, E. H., Kirkham, W. W. & Robinson, F. R. ( 1977; ). Neoplasms of Equidae. J Am Vet Med Assoc 170, 150–152.
    [Google Scholar]
  70. Syverton, T. J. ( 1952; ). The pathogenesis of the rabbit papilloma-to-carcinoma sequence. Ann N Y Acad Sci 54, 1126–1140.[CrossRef]
    [Google Scholar]
  71. Thomsett, L. R. ( 1979; ). Skin diseases of the horse. In Pract 1, 15–26.
    [Google Scholar]
  72. Tong, X. & Howley, P. M. ( 1997; ). The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc Natl Acad Sci U S A 94, 4412–4417.[CrossRef]
    [Google Scholar]
  73. Tong, X., Salgia, R., Li, J. L., Griffin, J. D. & Howley, P. M. ( 1997; ). The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase. J Biol Chem 272, 33373–33376.[CrossRef]
    [Google Scholar]
  74. Tong, X., Boll, W., Kirchhausen, T. & Howley, P. M. ( 1998; ). Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. J Virol 72, 476–482.
    [Google Scholar]
  75. Torrontegui, B. O. & Reid, S. J. ( 1994; ). Clinical and pathological epidemiology of the equine sarcoid in a referral population. Equine Vet Educ 6, 85–88.[CrossRef]
    [Google Scholar]
  76. Trenfield, K., Spradbrow, P. B. & Vanselow, B. ( 1985; ). Sequences of papillomavirus DNA in equine sarcoids. Equine Vet J 17, 449–452.[CrossRef]
    [Google Scholar]
  77. Vambutas, A., DeVoti, J., Pinn, W., Steinberg, B. M. & Bonagura, V. R. ( 2001; ). Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport. Clin Immunol 101, 94–99.[CrossRef]
    [Google Scholar]
  78. Vande Pol, S. B., Brown, M. C. & Turner, C. E. ( 1998; ). Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 16, 43–52.[CrossRef]
    [Google Scholar]
  79. Venuti, A. & Campo, M. S. ( 2002; ). The E5 protein of Papillomaviruses. In Progress in Medical Virology: Papillomaviruses, pp. 141–162. Edited by D. J. McCance. Iowa: Iowa State Press.
  80. Voss, J. L. ( 1969; ). Transmission of equine sarcoid. Am J Vet Res 30, 183–191.
    [Google Scholar]
  81. Wank, R. & Thomssen, C. ( 1991; ). High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352, 723–725.[CrossRef]
    [Google Scholar]
  82. Watson, R. E., Jr & Larson, K. A. ( 1974; ). Detection of tumor-specific antigens in an equine sarcoid cell line. Infect Immun 9, 714–718.
    [Google Scholar]
  83. Zimmermann, H., Koh, C. H., Degenkolbe, R., O'Connor, M. J., Muller, A., Steger, G., Chen, J. J., Lui, Y., Androphy, E. & Bernard, H. U. ( 2000; ). Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. J Gen Virol 81, 2617–2623.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18947-0
Loading
/content/journal/jgv/10.1099/vir.0.18947-0
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error